Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 6:10:100196.
doi: 10.1016/j.lanepe.2021.100196. eCollection 2021 Nov.

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands

Pauline Versteegen  1 , Guy A M Berbers  1 , Gaby Smits  1 , Elisabeth A M Sanders  1   2 , Fiona R M van der Klis  1 , Hester E de Melker  1 , Nicoline A T van der Maas  1
Affiliations

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands

Pauline Versteegen et al. Lancet Reg Health Eur. .

Abstract

Background: Pertussis is a respiratory disease and still endemic despite high vaccination coverage. In the Dutch national immunisation programme (NIP) whole cell pertussis (wP) priming vaccines for infants were replaced by acellular pertussis (aP) priming vaccines in 2005. Serosurveillance gives the opportunity to objectively monitor effects of changes in the NIP on infection prevalence and vaccine response in the population over time.

Methods: For this population-based cross-sectional serosurvey a representative sample of Dutch residents (0-89 years) was drawn in 2016/2017. Primary outcome was the percentage of participants with pertussis toxin specific antibody concentrations ≥ 100 IU/ml as an indicator of recent infection, and to identify groups possibly more vulnerable to pertussis infection. Percentages were compared with previous results from 2006/2007.

Findings: In total 7621 persons were included in the analysis. An increase in recent infections from 3•5% to 5•9% was found in the population from 7 years and older (n=6013) in 2016/2017 compared with 2006/2007. Most noteworthy increase was seen in 12-18-year-olds who were wP primed and aP boosted.

Interpretation: Infection prevalence is still increasing in the Netherlands inducing a risk of pertussis disease in vulnerable (age) groups. Delaying the preschool booster might prolong the period of protection during primary school and thereby possibly protect younger siblings. Extra boosters might be considered for risk populations like older adults and people with (pulmonary) co-morbidities, since they have higher chances of complications and hospitalisation.An unedited Dutch translation of the abstract is available in : Nederlandse samenvatting.

Funding: The Dutch Ministry of Health, Welfare, and Sport.

Keywords: Bordetella pertussis; cross-sectional, population-based study; immunoglobulin G; pertussis toxin; seroepidemiological study.

PubMed Disclaimer

Conflict of interest statement

None of the authors received payment or service from a third part at any time, nor does anyone have a financial relationship with entities in the bio-medical arena. None of the authors have any patents relevant to the work.

Figures

Fig 1
Fig. 1
Pertussis notifications
Fig 2
Fig. 2
Pertussis infection prevalence in 2016/2017 compared to 2006/2007
See this image and copyright information in PMC

References

    1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–382. doi: 10.1128/cmr.18.2.326-382.2005. - DOI - PMC - PubMed
    1. Cherry JD. Pertussis in Young Infants Throughout the World. Clin Infect Dis. 2016;63(suppl 4):S119–SS22. doi: 10.1093/cid/ciw550. - DOI - PMC - PubMed
    1. Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–455. doi: 10.1080/14760584.2019.1588727. - DOI - PubMed
    1. Schurink-van 't Klooster T, de Melker H. Rijksinstituut voor Volksgezondheid en Milieu RIVM; 2020. The National Immunisation Programme in the Netherlands: Surveillance and developments in 2019-2020. - DOI
    1. David S, Vermeer-de Bondt PE, van der Maas NAT. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. Vaccine. 2008;26(46):5883–5887. doi: 10.1016/j.vaccine.2008.07.105. - DOI - PubMed

LinkOut - more resources